Related stories
Akebia Therapeutics Says Vafseo Trial Meets Primary Endpoint in CKD Anemia
11:08 AM EST, 11/05/2026 (MT Newswires) -- Akebia Therapeutics (AKBA) said Thursday its Vocal trial
L impact | EQUITY | Nov 05, 2026, 04:12 PM UTC
Prysmian Schedules Financial Results Calls and Annual Shareholder Meeting
Prysmian Schedules Financial Results Calls and Annual Shareholder Meeting Prysmian’s board will
L impact | EQUITY | Nov 05, 2026, 04:12 PM UTC
Prysmian annuncia calendario degli eventi societari
Prysmian annuncia calendario degli eventi societari Prysmian riunirà il consiglio di amministraz
L impact | EQUITY | Nov 05, 2026, 04:12 PM UTC
POLENERGIA SA - WSTĘPNE WYBRANE SKONSOLIDOWANE WYNIKI FINANSOWE ZA DZIEWIĘĆ MIESIĘCY 2026 ROKU
L impact | EQUITY | Nov 05, 2026, 04:12 PM UTC
POLENERGIA - PRELIM. GROUP EBITDA FOR 9 MONTHS 2026 AMOUNTS TO PLN 332.5 MLN
L impact | EQUITY | Nov 05, 2026, 04:12 PM UTC
CHSN: trading halted on Nasdaq — volatility pause (11:12 AM ET)
Nasdaq halted trading in CHSN (volatility pause) at 11:12 AM ET.
M impact | EQUITY | Nov 05, 2026, 04:12 PM UTC